Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
81.75
-1.71 (-2.05%)
Apr 28, 2026, 1:09 PM EDT - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Transcatheter Aortic Valve Replacement Revenue
4.64B4.49B4.11B
Transcatheter Aortic Valve Replacement Revenue Growth
3.36%9.29%5.83%
Transcatheter Mitral and Tricuspid Therapies Revenue
610.50M550.60M352.10M
Transcatheter Mitral and Tricuspid Therapies Revenue Growth
10.88%56.38%78.19%
Surgical Structural Heart Revenue
1.05B1.03B981.30M
Surgical Structural Heart Revenue Growth
2.46%4.89%5.22%
Revenue (Total)
6.30B6.07B5.44B
Revenue (Total) Growth
3.89%11.55%8.57%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
3.64B3.54B3.21B
United States Revenue Growth
2.79%10.51%8.76%
Europe Revenue
1.62B1.52B1.32B
Europe Revenue Growth
6.64%14.81%11.99%
Japan Revenue
363.50M354.70M339.80M
Japan Revenue Growth
2.48%4.38%-3.14%
Rest of World Revenue
679.90M652.30M572.00M
Rest of World Revenue Growth
4.23%14.04%7.70%
Revenue (Total)
6.30B6.07B5.44B
Revenue (Total) Growth
3.89%11.55%8.57%
Updated Apr 23, 2026. Data Source: Fiscal.ai.